News searcher
ROVI signs a co-operation agreement for a clinical trial to study the efficacy and safety of bemiparin in patients hospitalised with pneumonia caused by COVID-19
The project will be coordinated and managed by Fundación de Investigación HM Hospitales
2 min
14 Apr, 2020
ROVI informs on the impact of Covid 19 on the company’s activities
The company has reduced the processes performed in person at its facilities to a minimum but is keeping all its...
6 min
02 Apr, 2020
ROVI will donate a million surgical masks to the Ministry of Health
Purchase of one million surgical masks
1 min
26 Mar, 2020
Operating income, growth figures, profitability and how our products have behaved
0 min
26 Feb, 2020
ROVI reports operating revenue growth of 26% and EBITDA growth of 106%
Summary of the financial results of 2019
6 min
26 Feb, 2020
ROVI announces the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union
Assessment process to grant marketing authorisation for Doria® in the European Union
2 min
31 Jan, 2020
ROVI updates its strategy in a meeting with shareholders, investors and analysts.
0 min
25 Nov, 2019
Javier López-Belmonte, Vicepresident and CFO of Laboratorios Farmacéuticos ROVI presents the financial results for the...
0 min
25 Nov, 2019
Summary of the financial results for the first nine months of 2019
5 min
07 Nov, 2019